Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Twist Bioscience Corporation
Pharmaceutical Preparation ManufacturingUnited States
Last verified 10 months agotwistbioscience.com
Twist Bioscience Corporation, a leader in the Pharmaceutical Preparation Manufacturing industry, is headquartered in the United States. Founded in 2013, the company has rapidly established itself as a pioneer in synthetic DNA production, catering to diverse sectors including biotechnology, pharmaceuticals, and agriculture.
Twist Bioscience's innovative approach to DNA synthesis allows for high-throughput, cost-effective solutions that are unique in the market. Their core products include synthetic genes, gene fragments, and other DNA-based tools, which are essential for research and development in various scientific fields.
With a strong market position, Twist Bioscience has achieved significant milestones, including partnerships with major pharmaceutical companies and advancements in gene therapy applications. Their commitment to quality and efficiency continues to drive their success in the rapidly evolving biotechnology landscape.
28
DitchCarbon score
-14 vs industry average
Twist Bioscience Corporation’s score of 28 is lower than 40% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Twist Bioscience Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Twist Bioscience Corporation's reported carbon emissions
Twist Bioscience Corporation: Carbon Emissions & Climate Commitments
Based in the US, Twist Bioscience Corporation, a pharmaceutical preparation manufacturer, is actively addressing its carbon footprint. In 2024, the company reported total Scope 1 and Scope 2 emissions of approximately 3,007,000 kg CO2e. This includes about 7,000 kg CO2e from Scope 1 emissions and approximately 3,000,000 kg CO2e from Scope 2 emissions.
Twist Bioscience has demonstrated its commitment to climate action by having its near-term emissions reduction targets "Committed" with the Science Based Targets initiative (SBTi). The company has also identified a carbon emission factor of 28,400 kg CO2e per oligo panel as a production emission factor.
The company's climate data, including emissions and SBTi targets, is directly reported by Twist Bioscience Corporation and not cascaded from a parent or related organisation.
Assessing Twist Bioscience Corporation as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Twist Bioscience Corporation and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Twist Bioscience Corporation’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Twist Bioscience Corporation10 months ago
28
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Twist Bioscience Corporation’s sustainability data and climate commitments
For the year 2024, Twist Bioscience Corporation, a pharmaceutical preparation manufacturer, reported total Scope 1 and Scope 2 carbon emissions of approximately 3,007,000 kg CO2e. This figure represents the company's direct emissions from its operations and indirect emissions from purchased electricity, heat, or steam. The company directly reports this climate data, demonstrating a substantial level of transparency in its environmental performance.
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more